Fortress Biotech Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +13.0% | +4,234.6% | +197.2% | -38.5% | +126.0% | +14.4% | +27.5% | +37.7% | -35.9% | -25.6% | +4.4% | |
| – | +157.7% | -15.1% | +15.5% | +7.2% | -12.2% | +2.0% | +44.9% | +18.0% | -25.9% | +91.5% | -11.9% | |
| – | +149.9% | -68.3% | -417.4% | – | – | -426.0% | – | – | – | – | – | |
| – | – | -62.0% | -213.3% | – | -184.4% | – | – | -102.0% | – | – | – | |
| – | – | -12.3% | -48.2% | +71.8% | +0.4% | -23.7% | +128.2% | -81.3% | +165.1% | +85.2% | -100.0% | |
| – | – | -176.9% | +586.9% | – | +6.8% | -135.6% | – | -156.6% | -90.8% | +613.3% | – | |
| – | – | +0.0% | +0.0% | +683.9% | +9.2% | +163.9% | +30.0% | +0.0% | -0.1% | -46.3% | -85.9% | |
| – | – | -98.8% | +170.0% | -113.9% | -89.7% | +191.7% | – | -104.9% | -66.6% | -100.0% | – | |
| – | – | -32.9% | +505.5% | -100.0% | +1,474,700.0% | -301.2% | -49.3% | – | -178.8% | -81.1% | -23.1% | |
| – | – | -29.6% | +250.5% | -66.3% | +189.7% | +17.5% | -13.6% | -49.4% | -56.5% | +115.8% | +9.6% | |
| – | – | -120.4% | – | -208.2% | – | +13.5% | -10.5% | -274.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.